Download PDF
CC BY-NC-ND 4.0 · Asian J Neurosurg 2019; 14(03): 828-833
DOI: 10.4103/ajns.AJNS_173_16
Original Article

The description of urodynamic study for bladder dysfunction in compressive myelo- or radiculo-pathy: A prospective study in an institutional setup

Nayil Khursheed
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Bilal Pahalwan
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Humam Nisar
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Altaf Ramzan
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Saleem Wani
1   Department of Urology, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Abrar Wani
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Sarbjit Singh
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Rouf Khawaja
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Arif Hamid
1   Department of Urology, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Hussain Arif
Department of Neurosurgery, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
,
Baldev Singh
1   Department of Urology, Sher-i-Institute of Medical Sciences, Srinagar, Jammu and Kashmir
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Purpose: To study the significance of filling cystometry with pressure flow studies and bladder electromyography (EMG) in assessment and management of neurogenic bladder with myelopathies and evaluated neurological recovery in the follow-up period. Methods: The study was a 3-year prospective urodynamic study in 63 patients, with traumatic and nontraumatic myelopathy. Bladder management was advised based on the cystometric findings. Neurological recovery and mode of bladder management were evaluated during follow-up after a minimum of 6 months. Results: Mean age was 44.6 years (range 10–80 years). Thoracolumbar area was most commonly involved. Cystometry revealed overactive detrusor in 46 patients, (17 had detrusor sphincter dyssynergia [DSD], 29 without DSD) and areflexic/underactive detrusor in 9 patients. Postvoid residual (>15% of voided urine) was significant in 27 patients. Neurological recovery was seen in 60.3%, whereas 22.2% showed no improvement (partial improvement in 4.8%) and 12.6% had normal bladder function both initially and at follow-up. Correlation between neurological recovery and bladder management was found to be insignificant (P > 0.05) using spearman's correlation coefficient. Conclusion: Filling cystometry with pressure flow studies and EMG study is valuable for the assessment and management of neurogenic bladder in patients with myelopathy. In neurogenic bladder management and follow-up, pressure flow studies help to prevent complications and upper urinary tract complications.

Key-words:

Compressive myelopathy - filling cystometry - neurogenic bladder - radiculopathy - spinal injury - urodynamic study

Financial support and sponsorship

Nil.




Publication History

Article published online:
09 September 2022

© 2019. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Webb DR, Fitzpatrick JM, O'Flynn JD. A 15-year follow-up of 406 consecutive spinal cord injuries. Br J Urol 1984;56:614-7.
  • 2 Tang DH, Colayco D, Piercy J, Patel V, Globe D, Chancellor MB. Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol 2014;14:74.
  • 3 Manack A, Motsko SP, Haag-Molkenteller C, Dmochowski RR, Goehring EL Jr., Nguyen-Khoa BA, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn 2011;30:395-401.
  • 4 Dong D, Xu Z, Shi B, Chen J, Jiang X, Wang H. Urodynamic study in the neurogenic bladder dysfunction caused by intervertebral disk hernia. Neurourol Urodyn 2006;25:446-50.
  • 5 Shenot PJ, Rivas DA, Watanabe T, Chancellor MB. Early predictors of bladder recovery and urodynamics after spinal cord injury. Neurourol Urodyn 1998;17:25-9.
  • 6 van Middendorp JJ, Hosman AJ, Pouw MH; EM-SCI Study Group, Van de Meent H. ASIA impairment scale conversion in traumatic SCI: Is it related with the ability to walk? A descriptive comparison with functional ambulation outcome measures in 273 patients. Spinal Cord 2009;47:555-60.
  • 7 Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007;26:228-33.
  • 8 Cong ML, Gong WM, Zhang QG, Sun BW, Liu SH, Li L, et al. Urodynamic study of bladder function for patients with lumbar spinal stenosis treated by surgical decompression. J Int Med Res 2010;38:1149-55.
  • 9 Wyndaele JJ, De Taeye N. Early intermittent self-catheterisation after spinal cord injury. Paraplegia 1990;28:76-80.
  • 10 Wyndaele JJ, Madersbacher H, Kovindha A. Conservative treatment of the neuropathic bladder in spinal cord injured patients. Spinal Cord 2001;39:294-300.
  • 11 Patki P, Woodhouse J, Hamid R, Shah J, Craggs M. Lower urinary tract dysfunction in ambulatory patients with incomplete spinal cord injury. J Urol 2006;175:1784-7.
  • 12 Generao SE, Dall'era JP, Stone AR, Kurzrock EA. Spinal cord injury in children: Long-term urodynamic and urological outcomes. J Urol 2004;172:1092-4.
  • 13 McGuire EJ. The role of urodynamic investigation in the assessment of benign prostatic hypertrophy. J Urol 1992;148:1133-6.
  • 14 McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981;126:205-9.
  • 15 Gerridzen RG, Thijssen AM, Dehoux E. Risk factors for upper tract deterioration in chronic spinal cord injury patients. J Urol 1992;147:416-8.
  • 16 Chou FH, Ho CH, Chir MB, Linsenmeyer TA. Normal ranges of variability for urodynamic studies of neurogenic bladders in spinal cord injury. J Spinal Cord Med 2006;29:26-31.
  • 17 Liu CW, Attar KH, Gall A, Shah J, Craggs M. The relationship between bladder management and health-related quality of life in patients with spinal cord injury in the UK. Spinal Cord 2010;48:319-24.
  • 18 Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164(3 Pt 1):692-7.
  • 19 Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: A randomised, double-blind, placebo-controlled trial. Eur Urol 2011;60:742-50.
  • 20 Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004;45:510-5.
  • 21 Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: Results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005;174:196-200.
  • 22 Lioyd LK. Long term follow up of neurogenic bladder. Phys Med Rehabil Clin N Am 1993;4:391-409.
  • 23 Trop CS, Bennett CJ. Autonomic dysreflexia and its urological implications: A review. J Urol 1991;146:1461-9.
  • 24 Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261-74.
  • 25 Schäfer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, et al. Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261-74.
  • 26 Abrams P. Urodynamic investigation led to new criteria for the selection of patients for operative treatment. J Urol 1983;147:316.